OTCMKTS:MKGAF - Merck KGaA Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $99.9550 -0.73 (-0.73 %) (As of 05/23/2019 03:39 PM ET)Previous Close$100.69Today's Range$99.9550 - $100.4552-Week Range$95.6550 - $115.70Volume301 shsAverage Volume176 shsMarket CapitalizationN/AP/E Ratio15.47Dividend YieldN/ABeta0.59 ProfileChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It offers prescription medicines to treat cancer, multiple sclerosis, infertility, growth deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, as well as squamous cell carcinoma of the head and neck; diagnostics and prescription drugs for allergen immunotherapy; and fertility treatments. The company also provides life science products and services for use in the discovery, development, and manufacture of drug therapies, as well as in laboratories; and specialty chemicals for use in displays, computer chips, surfaces, Integrated circuits, microelectronic systems, anti-reflection coatings, and cosmetics. It has alliances with Pfizer Inc., Bristol-Myers Squibb Company, Intrexon Corporation, Avillion LLP., F-star Delta Ltd, SFJ Pharmaceuticals Group, Alibaba Health, Checkmate Pharmaceuticals, Solvias, and Leap Therapeutics, Inc., as well as a collaboration with Daiichi Sankyo Company, Limited. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft. Receive MKGAF News and Ratings via Email Sign-up to receive the latest news and ratings for MKGAF and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:MKGAF Previous Symbol CUSIPN/A CIKN/A Webhttp://www.merckgroup.com/ Phone49-61-517-20Debt Debt-to-Equity Ratio0.39 Current Ratio1.08 Quick Ratio0.76Price-To-Earnings Trailing P/E Ratio15.47 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$17.52 billion Price / SalesN/A Cash Flow$36.3473 per share Price / Cash Flow2.75 Book Value$157.47 per share Price / Book0.63Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees54,009 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Merck KGaA (OTCMKTS:MKGAF) Frequently Asked Questions What is Merck KGaA's stock symbol? Merck KGaA trades on the OTCMKTS under the ticker symbol "MKGAF." How were Merck KGaA's earnings last quarter? Merck KGaA (OTCMKTS:MKGAF) announced its quarterly earnings data on Thursday, March, 7th. The company reported $1.39 earnings per share (EPS) for the quarter. The company earned $4.44 billion during the quarter. View Merck KGaA's Earnings History. Has Merck KGaA been receiving favorable news coverage? Press coverage about MKGAF stock has trended somewhat positive this week, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Merck KGaA earned a news impact score of 0.7 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 7.0 out of 10, meaning that recent press coverage is likely to have an effect on the company's share price in the near future. Who are some of Merck KGaA's key competitors? Some companies that are related to Merck KGaA include Advanced Accelerator Application (AAAP), Affymax (AFFY), American Oriental Bioengineering (AOBI), Aralez Pharmaceuticals (ARLZ), ARMO Biosciences (ARMO), Bohai Pharmaceuticals Group (BOPH), Cardiome Pharma (CRME), Concordia International (CXRXD), Concordia International (CXRX), Depomed (DEPO), Egalet (EGLT), Eleven Biotherapeutics (EBIO), Epirus Biopharmaceuticals (EPRSQ), ERBA Diagnostics (ERBA) and FutureWorld (FWDG). What other stocks do shareholders of Merck KGaA own? Based on aggregate information from My MarketBeat watchlists, some companies that other Merck KGaA investors own include AptarGroup (ATR), SM Energy (SM), Welltower (WELL), iShares Russell Mid-Cap Value ETF (IWS), GlaxoSmithKline (GSK), EVRAZ (EVR), Derwent London (DLN), Aberdeen Asian Income Fund (AAIF), Siltronic (WAF) and Allianz (ALV). Who are Merck KGaA's key executives? Merck KGaA's management team includes the folowing people: Dr. Stefan Oschmann, Chairman of Exec. Board & CEO (Age 62)Dr. Marcus Kuhnert, CFO & Member of Exec. Board (Age 51)Dr. Kai Beckmann, CEO of Performance Materials & Member of the Exec. Board (Age 54)Dr. Udit Batra, CEO of Life Science & Member of Exec. Board (Age 48)Ms. Belén Garijo López M.D., CEO of Healthcare & Member of the Exec. Board (Age 59) How do I buy shares of Merck KGaA? Shares of MKGAF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Merck KGaA's stock price today? One share of MKGAF stock can currently be purchased for approximately $99.9550. What is Merck KGaA's official website? The official website for Merck KGaA is http://www.merckgroup.com/. How can I contact Merck KGaA? Merck KGaA's mailing address is Frankfurter Strasse 250, Darmstadt 2M, 64293. The company can be reached via phone at 49-61-517-20 or via email at [email protected] MarketBeat Community Rating for Merck KGaA (OTCMKTS MKGAF)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 137 (Vote Outperform)Underperform Votes: 155 (Vote Underperform)Total Votes: 292MarketBeat's community ratings are surveys of what our community members think about Merck KGaA and other stocks. Vote "Outperform" if you believe MKGAF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MKGAF will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/23/2019 by MarketBeat.com StaffFeatured Article: What are earnings reports? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.